- link Copy Url - [ Share on twitter ](https://twitter.com/intent/tweet?text=Alexion Launches 2020 CSR Report Written From Employee Perspective https://www.3blmedia.com/markdownify/node/324481?absolute=1&via=3blnews "link to 3 B L Media's Twitter") - [ Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/324481?absolute=1 "link to 3 B L Media's Linkedin") - [ Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/324481?absolute=1 "link to 3 B L Media's Facebook") - [ email Share via email ](mailto:?subject=Alexion Launches 2020 CSR Report Written From Employee Perspective&body=ESG News from Alerts https://www.3blmedia.com/markdownify/node/324481?absolute=1 "Share via email") [Research, Reports & Publications](/CSR-News/research-reports-publications) # Alexion Launches 2020 CSR Report Written From Employee Perspective Apr 7, 2021 10:00 AM ET ![](/sites/default/files/styles/carousel_2x/public/images/AlexionCSR20_Report_03.23_COVER.jpg) Alexion, a global biopharmaceutical company (NASDAQ: ALXN), is committed to all the communities we engage with including patients, caregivers and their families; our valued employees and future talent; our neighbors around the world; investors; patient organizations; suppliers; business partners and others. This collective passion comes to life in our 2020 Corporate Social Responsibility (CSR) report, *Dear Communities,* which is written from the first-person perspective of Alexion employees. Alexion CEO Ludwig Hantson embodies the personal tone in his opening words: *“There is no doubt that 2020 was a year of change – it changed the way we live, the way we work and the way we serve our communities. Yet, with all of the change, I was reminded of an important truth – we are all human, and together we are resilient.”* At Alexion, CSR encompasses broad environmental, social and governance (ESG) considerations. We are pleased to report that our ESG efforts were recognized in 2020 by several respected ranking organizations: - **Lowest ESG risk of any biotech company (No. 1 ranking) according to Sustainalytics - **“Prime” designation by ISS ESG Ratings** - **Top 20 in the healthcare and life sciences sector on the Newsweek America’s Most Responsible Companies 2021 list** Alexion’s framework for executing on our commitments and reporting our progress is expressed as an acronym: CSR-STAR, representing four focus areas – SERVE, TRANSFORM, ADVANCE and REDEFINE – built on a foundation of Ethics & Compliance. Alexion is delivering on aspirations in each of these areas, as told by our employees in the report and in the highlights below: **SERVE Communities and Sustain Our Planet** - *Leanne B., Senior Manager CSR,* shares how we expanded our annual global volunteerism event from a single day to a full week in 2020 and pivoted to a 100% virtual experience so that employees from 20-plus countries could participate. - *Tamar T., Vice President Government Affairs and Policy,* introduces The Alexion Charitable Foundation (ACF) as its Chairperson. Launched in February 2020, the ACF provided $2.4 million to organizations helping the rare disease community cope with the impacts of COVID-19, as well as those supporting frontline workers and communities in need. - *Joe P., Director, Environmental, Health and Safety,* and Stephen B., Associate Director, Environmental Health and Safety*, author a section on Alexion’s approach to environmental, health and safety. Here, they describe Alexion’s efforts to assess risks associated with climate change and perform environmental, health and safety audits. **TRANSFORM Patient Lives** - *Wendy E., Vice President of Patient Experience, STAR and Patient Advocacy,* and *Stephanie W., Vice President of Employee Experience,* discuss efforts to drive patient centricity by “truly partnering with our patient community to understand their lived experience and deliver meaningful impact for them.” - *Judy C., Head of STAR Strategy and Planning,* speaks to Alexion’s annual workshops with patients and stakeholders to further patient centricity. In 2020, this uncovered a need for mental health resources across our portfolio, inspiring teams to co-create solutions. - *Brian M., Vice President, Global Medicine Leader, and others* share how we’re including the perspectives and inputs of patients and caregivers when creating protocols and patient-informed consent documents for early clinical development plans and Phase II/III clinical trials. **ADVANCE Our People and Our Company** - *Uzair Q.,* Alexion’s recently appointed *Chief Diversity Officer*, sets forth our unique vision of diversity, inclusion and belonging (DI&B), which includes a new “DI&B Innovation Factory” to produce bold ideas. - *Betel G., Lead of Clinical Trials Diversity DI&B Innovation Pod,* and *Gwen H., Member of Clinical Trials Diversity DI&B Innovation Pod,* report on the launch of Alexion’s cross-functional Diversity in Clinical Trials team, which aims to enhance clinical trials accessibility and reach a broader, more diverse pool of potential patients. - *Sonia S., Head of Culture,* explains Alexion’s unique and well-defined culture and reports a significant rise in a critical measure of employee loyalty at Alexion. - *Rohita S., Associate Director, Culture and Stakeholder Insights,* provides an overview of Alexion’s one-of-a-kind, experiential series, LEAP (Learn, Evolve, Activate and deliver for Patients), which immerses Alexion employees in the patient experience. - *Alex S., Head of CSR and President, Alexion Charitable Foundation,* introduces Alexion’s efforts to advance Brain Health, which extend beyond mental health to the broader physical, emotional and social factors that impact our well-being. - *Ellen C.*, *Chief Legal Officer and Corporate Secretary and CSR Executive Sponsor*, reinforces how CSR defines our approach to the business decisions we make as an organization. **REDEFINE Living with a Rare Disease or Devastating Condition** - *Sharon B*., *Head of Research, Data Sciences, Genomics, Bioinformatics and Diagnostics,* shares the importance of receiving an accurate rare disease diagnosis as early as possible. Alexion is working to support such efforts, including being part of a collaborative effort that achieved a new record in December 2020 for the fastest genetic-testing diagnosis. - *Moke S*.*, Head of Development Operations and Quantitative Sciences,* shares how Alexion built its own data modeling solution for tracking the geographic spread of COVID-19 to gauge how our clinical trials might be impacted and, potentially, adjusted. - *Anna P., Executive Medical Director, Global Medical Affairs Leader*, *HPP and Amyloidosis*, addresses the importance of patient registries and how Alexion establishes them to gather patient inputs and perspectives. **Ethics & Compliance: Our Foundation** - *Indrani F.*, *Chief Compliance Officer*, provides an overview of integrity at Alexion and introduces our Global Compliance Champions. - *Loren B., Director, Enterprise Programs,* talks about Alexion’s Integrity Matters Week, which provides colleagues with opportunities to hear from patient organizations, behavioral science experts and Alexion leaders. - *Bryan M., Director, Global Environmental Health and Safety,* explains how Alexion’s Strategic Sourcing and EHS teams are working to conduct ESG risk assessments that encompass evaluations of our suppliers and vendors. - *Ty B., Sourcing Operations Senior Specialist,* speaks to Alexion’s efforts to support supplier diversity, including appointing a dedicated resource to analyze and manage our program. To learn more about CSR at Alexion, please visit **Media Contact** Lisa Taylor, 857-338-9025 Senior Director, Corporate Communications [Read the Report](https://csr.alexion.com/) [![3BL logo ](/sites/default/files/2023-06/3BL%20FULL%20LOGO_MIDNIGHT_MEDIUM_0.png)](/profiles/alerts) ### More from Alerts ###### [U.S. Dairy Publishes 2023-2024 Sustainability Report](/news/us-dairy-publishes-2023-2024-sustainability-report) Nov 18, 2025 9:00 AM ET ###### [Employee Dedication Drives Progress Toward Animals, People and Planet Goals in Aurora Organic Dairy’s 2025 Sustainability Report](/news/employee-dedication-drives-progress-toward-animals-people-and-planet-goals-aurora-organic) Sep 10, 2025 8:00 AM ET ###### [Takeda Report Highlights Company’s Commitment to Cutting-Edge Science, Putting Patients First](/news/takeda-report-highlights-companys-commitment-cutting-edge-science-putting-patients-first) Jul 8, 2025 9:00 AM ET ###### [Kinross Releases 2024 Sustainability Report](/news/kinross-releases-2024-sustainability-report) Jun 10, 2025 10:00 AM ET ###### [Blackbaud’s 2024 Impact Report Highlights Continued Commitment to Corporate Social Responsibility](/news/blackbauds-2024-impact-report-highlights-continued-commitment-corporate-social-responsibility) May 29, 2025 11:00 AM ET ###### [Vancity Restores Profitability and Stays True to Its Co-Operative Values](/news/vancity-restores-profitability-and-stays-true-its-co-operative-values) May 14, 2025 6:00 AM ET ###### [Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report](/news/schrodinger-demonstrates-corporate-sustainability-progress-2024-report) Apr 30, 2025 10:00 AM ET ###### [Ancestry Publishes 2024 Annual Impact Report, Highlighting Corporate Commitments & Progress](/news/ancestry-publishes-2024-annual-impact-report-highlighting-corporate-commitments-progress) Apr 15, 2025 9:00 AM ET